With a new two-year, $700,000 grant from Breakthrough T1D, Dr. Matthew E. Brown and his team will be creating and studying hypoimmune, insulin-producing, stem cell-derived islet-like clusters as a potential new treatment for T1D.
[University of Wisconsin School of Medicine and Public Health]
